Close X
Attorney Spotlight

What emerging trend in shareholder litigation does Britt Latham find most interesting in his practice today?    Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more


Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

Timothy Van Hal

Associate

Nashville
(615) 742-7894 TEL
(615) 742-0498 FAX

Timothy Van Hal

Associate

Nashville
(615) 742-7894 TEL
(615) 742-0498 FAX
Nashville
(615) 742-7894 TEL
(615) 742-0498 FAX

Tim Van Hal advises clients on a variety of corporate, securities and capital markets law matters including advice related to corporate restructurings, securities offerings and transactions, mergers and acquisitions, corporate refinancings and general corporate matters. He has worked on a variety of debt and equity deals serving corporate clients as well as private equity houses and underwriting banks as well as varied mergers and acquisitions, block trades, and other smaller capital markets matters. Tim works across a range of industries including manufacturing, financial services, pharmaceuticals, biotech, REITs and online retailers.

Prior to joining Bass, Berry & Sims, Tim practiced at Freshfields Bruckhaus Deringer LLP in Frankfurt, Germany, as part of their U.S. Capital Markets team.

Memberships

American Health Lawyers Association (AHLA)

News

View More

Representative Experience

View More

Publications

View More

Accolades

Vanderbilt Journal of Entertainment and Technology Law – Managing Editor

Vanderbilt Law School – Law and Business Certificate, Chancellor's Law Scholar

Phi Beta Kappa

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.